Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. (Q50236829)

28 February 2018

title

Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. (English)

1 reference

28 February 2018

main subject

phase II clinical trial

0 references

mesenchymal stem cell

1 reference

2

1 reference

28 February 2018

author name string

Ki Tae Suk

1

1 reference

28 February 2018

Moon Young Kim

3

1 reference

28 February 2018

Chang Wook Kim

4

1 reference

28 February 2018

Ja Kyung Kim

5

1 reference

28 February 2018

Hana Park

6

1 reference

28 February 2018

Seong Gyu Hwang

7

1 reference

28 February 2018

Dong Joon Kim

8

1 reference

28 February 2018

Byung Seok Lee

9

1 reference

28 February 2018

Sae Hwan Lee

10

1 reference

28 February 2018

Hong Soo Kim

11

1 reference

28 February 2018

Jae Young Jang

12

1 reference

28 February 2018

Chang-Hyeong Lee

13

1 reference

28 February 2018

Byung Seok Kim

14

1 reference

28 February 2018

Yoon Ok Jang

15

1 reference

28 February 2018

Mee Yon Cho

16

1 reference

28 February 2018

Eun Sun Jung

17

1 reference

28 February 2018

Yong Man Kim

18

1 reference

28 February 2018

Si Hyun Bae

19

1 reference

28 February 2018

Soon Koo Baik

20

1 reference

28 February 2018

language of work or name

English

0 references

publication date

23 June 2016

1 reference

28 February 2018

published in

Hepatology

1 reference

28 February 2018

volume

64

1 reference

28 February 2018

issue

6

1 reference

28 February 2018

page(s)

2185-2197

1 reference

28 February 2018

Alcoholic liver disease: pathogenesis and new therapeutic targets

cites work

1 reference

Revision and update on clinical practice guideline for liver cirrhosis.

21 January 2018

1 reference

Assessment for Risk of Bias in Systematic Reviews and Meta-Analyses in the Field of Hepatology

21 January 2018

1 reference

Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).

21 January 2018

1 reference

Liver transplantation in patients with alcoholic liver disease

21 January 2018

1 reference

Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues

21 January 2018

1 reference

Fetal liver hematopoietic stem cell niches associate with portal vessels

21 January 2018

1 reference

Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.

21 January 2018

1 reference

Artificial and bioartificial liver devices: present and future

21 January 2018

1 reference

Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow

21 January 2018

1 reference

Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study.

21 January 2018

1 reference

Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis

21 January 2018

1 reference

Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.

21 January 2018

1 reference

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis.

21 January 2018

1 reference

Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model

21 January 2018

1 reference

Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice

21 January 2018

1 reference

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

21 January 2018

1 reference

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives

21 January 2018

1 reference

Global burden of alcoholic liver diseases

21 January 2018

1 reference

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

21 January 2018

1 reference

The model for end-stage liver disease (MELD)

21 January 2018

1 reference

Isolation and identification of mesenchymal stem cells from human fetal pancreas.

21 January 2018

1 reference

Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension

21 January 2018

1 reference

Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells

21 January 2018

1 reference

Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells

21 January 2018

1 reference

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis

21 January 2018

1 reference

Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients

21 January 2018

1 reference

Mesenchymal stem cell therapy for liver fibrosis

21 January 2018

1 reference

Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.

21 January 2018

1 reference

Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.

21 January 2018

1 reference

Model for end-stage liver disease (MELD) and allocation of donor livers

21 January 2018

1 reference

Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study

21 January 2018

1 reference

The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis

21 January 2018

1 reference

EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease

21 January 2018

1 reference

7 January 2021

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes

1 reference

7 January 2021

Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism

1 reference

7 January 2021

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28693

1 reference

28 February 2018

PubMed ID

27339398

1 reference

28 February 2018